NASDAQ: BLFS
- Last Close 13.81
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Investment Style Small Growth
- Day Range 13.74 – 14.25
- Year Range 10.48 – 26.89
- Market Cap 600.5981 Mil
- Volume / Avg 442,024.0 / 448,176.7
- Price / Sales 3.66
- Price / Book 1.70
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis BLFS
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
About Quantitative Ratings
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Unlock Our Full Analysis With Morningstar Investor
Company Profile BLFS
Business Description
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
BioLife Solutions Inc
XNAS: BLFS
| CryoPort Inc
XNAS: CYRX
| TELA Bio Inc Ordinary Shares
XNAS: TELA
| Misonix Inc
XNAS: MSON
| |
Price
| 13.81 | 13.71 | 8.00 | — |
Currency
| USD | USD | USD | — |
Change
| −$0.24 (1.71%) | +$0.03 (0.22%) | +$0.14 (1.78%) | — |
Market Cap
| 600.60 Mil | 670.13 Mil | 195.90 Mil | — |
Industry
| Medical Instruments & Supplies | Integrated Freight & Logistics | Medical Devices | Medical Devices |
Sector
|
Healthcare
|
Industrials
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for BioLife Solutions Inc Stock
No. BLFS does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
BLFS’s market cap is 600.60 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
BLFS’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
BLFS’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare BLFS’s historical performance against its industry peers and the overall market.